FitLife Brands, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FTLF research report →
Range $21 – $40
Price Chart
About the company
FitLife Brands, Inc. supplies dietary supplements to health-conscious individuals across the United States and globally. Their extensive product line caters to various needs, encompassing weight management, overall well-being, and athletic performance.
- CEO
- Dayton Robert Judd
- IPO
- 2007
- Employees
- 81
- HQ
- Omaha, NE, US
Get TickerSpark's AI analysis on FTLF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $58.22M
- P/E
- 9.18
- Fwd P/E
- 8.67
- PEG
- 0.09
- P/S
- 0.61
- P/B
- 1.28
- EV/EBITDA
- 8.26
- Div Yield
- 0.00%
- Gross Margin
- 36.45%
- Op Margin
- 11.19%
- Net Margin
- 6.65%
- ROE
- 14.83%
- ROIC
- 10.34%
Latest fiscal year · YoY change
- Revenue
- $81.46M+26.4%
- Gross Profit
- $31.45M+12.0%
- Op Income
- $12.14M
- Net Income
- $6.33M-29.6%
- EPS
- $0.68-30.4%
- OCF Growth
- -22.6%
- FCF Growth
- -22.9%
- 52W High
- $19.23
- 52W Low
- $6.07
- 50D MA
- $8.57
- 200D MA
- $10.59
- Beta
- -0.00
- RSI (14)
- 28
- Avg Volume
- 13.08K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
FitLife posted higher Q3 revenue and earnings on stronger online sales and a full quarter of Irwin, while management focused on cost savings, margin support from forward-buying ingredients, and ongoing weakness in MRC and specialty retail.· November 16, 2026
- Q3 revenue rose 9% year over year to $25.6 million, with online revenue up 15% to $11.8 million and 46% of total sales.
- Gross margin was 37.7%, up from 37.2% a year ago and up sequentially from 37.0% in Q2; net income rose 71% to $1.6 million and EPS was $0.16 diluted vs. $0.09 last year.
- Adjusted EBITDA was $3.3 million versus $3.8 million a year ago; trailing-12-month revenue was $103.4 million and adjusted EBITDA was $13.7 million.
- Management completed a restructuring expected to cut annual operating expense by about $1.2 million starting in Q4, with the full P&L benefit expected in SG&A.
- The company highlighted continued pressure in MRC, GNC, and specialty retail, partially offset by all-time highs in online sales for Irwin and MusclePharm.
Total revenue was $25.6 million in Q3 2026, up 9% year over year. Gross margin was 37.7% versus 37.2% a year ago, with gross margin at Legacy FitLife of 41.6% and Irwin at 34.0%. Net income was $1.6 million versus $0.9 million last year, diluted EPS was $0.16 versus $0.09, basic EPS was $0.17 versus $0.10, and adjusted EBITDA was $3.3 million versus $3.8 million. Online revenue was $11.8 million, up 15% year over year. Management did not provide formal next-quarter or full-year guidance, but said the restructuring should reduce annual operating expense by about $1.2 million beginning in Q4 2026, and that online momentum, cost actions, and working-capital normalization are expected to support results going forward.
Management’s message was that the business is steadier than the headline channel weakness suggests, with the combined company relatively stable over the last four quarters and stronger brands offsetting problem areas. They emphasized building a stronger supply chain, a new product pipeline, and a more efficient cost base, while continuing to adapt to Amazon algorithm changes and consumer weakness. Tone was cautious but constructive, with repeated emphasis that the issues are concentrated in MRC and specialty retail rather than across the whole portfolio.
The CFO discussed a quarter with 9% revenue growth, 37.7% gross margin, and $3.3 million of adjusted EBITDA, while noting $0.3 million of restructuring expense in Q3. He said the restructuring is expected to lower annual operating expense by about $1.2 million, with savings starting in Q4 and flowing through G&A, and he pointed to additional occupancy savings from the Los Angeles lease renewal. On the balance sheet, debt was $39.3 million, net debt was $38.6 million, and working capital rose to $13.1 million as the company deliberately forward-bought whey protein and fish oil; he said the weighted average cost of debt is about 6.7% and free cash flow will continue to be used for debt reduction.
Analysts focused on whether the $1.2 million restructuring savings would show up immediately, and management said Q4 should see the full benefit, with some cash impact trailing into Q4 from the Q3 charge. Questions also centered on MRC’s ongoing decline, and management said the brand is still falling year over year but the sequential decline may be moderating somewhat. On margins, management explained that Irwin’s online economics are held back by Amazon fees, lower price points, glass-bottle prep costs, and shipping complexity, while MusclePharm margins have improved into the mid-20% range from around 20% as the company moved away from lower-margin international sales and benefited from forward-bought protein.
The positive case is that FitLife is growing online, with Irwin and MusclePharm hitting all-time highs during the quarter and total online revenue up 15% year over year. Management also believes recent restructuring, lease savings, and forward-buying of key inputs should support margins and cash generation, while the business overall has stayed relatively stable for four straight quarters.
The main risks are continuing declines in MRC and weakness in specialty retail, especially GNC franchise locations and health food stores, which management said are still pressuring sales. Gross margin may face pressure once the company works through lower-cost inventory and starts buying more ingredients at spot-market prices, and management acknowledged that Amazon algorithm changes remain a persistent challenge.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 84.8%
- Shares Outstanding
- 9.39M
- Float Shares
- 7.96M
of shares held by institutions
43 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 205.06K | ▲ 4.51K |
| Vanguard Capital Management LLC | 154.25K | 0 |
| Mink Brook Asset Management LLC | 80.63K | ▲ 34.00K |
| Geode Capital Management, LLC | 49.05K | 0 |
| Horizon Kinetics Asset Management LLC | 44.50K | ▼ 100.50K |
| Vanguard Fiduciary Trust Co | 26.22K | 0 |
| Bard Associates Inc | 22.74K | ▲ 1.56K |
| Millennium Management LLC | 18.96K | ▼ 4.50K |
| State Street Corp | 16.34K | 0 |
| Susquehanna International Group, Llp | 15.26K | ▼ 2.74K |
| Blackrock, Inc. | 13.45K | ▼ 21.82K |
| Dimensional Fund Advisors LP | 10.33K | 0 |
Held by 29 ETFs
Biggest fund positions in FTLF by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 28, 26 | York Jakob | other | 4,000 |
| Aug 19, 26 | Pappas Shannon K. | buy | 1,000 |
| May 15, 26 | Hansen Ryan P. | other | 50,000 |
| May 15, 26 | Hansen Ryan P. | other | 46,500 |
| May 15, 26 | Hansen Ryan P. | other | 28,500 |
| Jan 15, 26 | Yakatan Seth | buy | 164 |
| Dec 15, 25 | Yakatan Seth | buy | 139 |
| Sep 15, 25 | Yakatan Seth | buy | 142 |
| Aug 25, 25 | Yakatan Seth | buy | 148 |
| Dec 31, 25 | Yakatan Seth | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FTLF coverage
Recent articles, reports, and earnings notes.
No research on FTLF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FTLF report →FitLife Brands, Inc. (FTLF) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 17
FitLife Brands Q3 Earnings Call Highlights
marketbeat.com · Nov 16
FitLife Brands Inc. (FTLF) Q3 Earnings and Revenues Lag Estimates
zacks.com · Nov 16
FitLife Brands Announces Third Quarter 2026 Results
globenewswire.com · Nov 16
FitLife Brands Announces Third Quarter Earnings Call
globenewswire.com · Nov 2
Alluvial Capital Management's Q3 2026 Top 10 Holdings
seekingalpha.com · Oct 26
FitLife Brands Eyes Acquisitions, Margin Gains to Offset Organic Growth Headwinds
marketbeat.com · Oct 24
Should Value Investors Buy FitLife Brands (FTLF) Stock?
zacks.com · Oct 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.